MedPath

Effect of different doses of ketamine on prevention of fentanyl induced coughing

Phase 3
Conditions
Candidate patients for surgery under general anesthesia using fentanyl.
Registration Number
IRCT20200825048515N55
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
56
Inclusion Criteria

Age category 65-18 years
Candidate for surgery under general anesthesia using fentanyl
American Society of Anesthesiologists (ASA) I or II
Satisfaction to participate in the study

Exclusion Criteria

Underlying diseases (including heart failure, respiratory, liver, kidney, myocardial ischemic disease, myocardial infarction, hypertension above 140/90 mm Hg, tachycardia (heart rate above 100 beats per minute), depression, asthma, chronic cough)
History of allergy to the studied drugs
Smoking, addiction
Having an upper respiratory infection within the last month
Use of drugs such as angiotensin converting enzyme inhibitors (ACEIs), antidepressants (over the past two weeks), and steroids (over the past two weeks) that interfere with the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of cough. Timepoint: Every 3 minutes during induction of anesthesia from the time of drug injection until 10 minutes after endotracheal intubation. Method of measurement: Fentanyl-Induced Cough Scale (FIC).
Secondary Outcome Measures
NameTimeMethod
Systolic blood pressure. Timepoint: Every 3 minutes during induction of anesthesia from the time of drug injection until 10 minutes after endotracheal intubation. Method of measurement: Monitoring device.;Diastolic blood pressure. Timepoint: Every 3 minutes during induction of anesthesia from the time of drug injection until 10 minutes after endotracheal intubation. Method of measurement: Monitoring device.;Hear rate. Timepoint: Every 3 minutes during induction of anesthesia from the time of drug injection until 10 minutes after endotracheal intubation. Method of measurement: Monitoring device.;Oxygen saturation (SPO2). Timepoint: Every 3 minutes during induction of anesthesia from the time of drug injection until 10 minutes after endotracheal intubation. Method of measurement: Monitoring device.
© Copyright 2025. All Rights Reserved by MedPath